Anika Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:ANIK) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 2.63 M1.58 M130 K189 K6.23 M 8.13 M Cash from investing activities 1.82 M1.31 M1.67 M-539 K-534 K 1.91 M Cash from financing activities 3.99 M5.35 M5.44 M-179 K13 K 10.63 M Free cash flow 1.41 M275 K-2.69 M-1.28 M4.34 M 648 K

Noticias

Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

Anika 4Ç 2025 sunumu: ticari kanal büyümesi OEM düşüşünü telafi etti

Anika Q4 2025 slides: commercial surge offsets OEM decline

Anika kazancı $0,45 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Anika earnings beat by $0.45, revenue topped estimates

Lumicell appoints Cheryl Blanchard to board of directors

Anika Therapeutics, Stephen Griffin’i yeni CEO olarak atadı

Anika Therapeutics names Stephen Griffin as new CEO

Anika 2025 3. Çeyrek: Ticari büyüme OEM düşüşünü dengeliyor

Anika Q3 2025 slides: Commercial growth offsets OEM decline

Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates

Anika earnings beat by $0.22, revenue was in line with estimates